249 related articles for article (PubMed ID: 6977469)
1. [Effect of radiochemotherapy and splenectomy on lymphoid subclasses in patients with Hodgkin's lymphoma in complete remission].
Leoni P; Montroni M; Montillo M; Salvi A; Centurioni R; Fanciulli E
G Clin Med; 1981 Oct; 62(10):685-92. PubMed ID: 6977469
[No Abstract] [Full Text] [Related]
2. [Proportions and absolute count of T- and B-lymphocytes in peripheral blood and their blastic transformation induced by mitogens in splenectomized and non-splenectomized patients with Hodgkin's disease].
Pluzańska A
Acta Haematol Pol; 1978; 9(1):37-44. PubMed ID: 307325
[TBL] [Abstract][Full Text] [Related]
3. B and T lymphocytes in Hodgkin's disease. Analysis at diagnosis and following therapy.
Gajl-Peczalska KJ; Bloomfield CD; Sosin H; Kersey JH
Clin Exp Immunol; 1976 Jan; 23(1):47-55. PubMed ID: 1083318
[TBL] [Abstract][Full Text] [Related]
4. Effects of radiochemotherapy and splenectomy on cellular immunity in long-term survivors of Hodgkin's disease and non-Hodgkin's lymphoma.
Steele R; Han T
Cancer; 1978 Jul; 42(1):133-9. PubMed ID: 667791
[TBL] [Abstract][Full Text] [Related]
5. The immediate effects of splenectomy, radiotherapy and intensive chemotherapy on the immune status of patients with malignant lymphoma.
Hancock BW; Bruce L; Ward AM; Richmond J
Clin Oncol; 1977 Jun; 3(2):137-44. PubMed ID: 872467
[No Abstract] [Full Text] [Related]
6. [Immunity in Hodgkin's lymphoma].
Danieli G; Montroni M; Leoni P; Magelli L; Totti S
G Clin Med; 1975; 56(1):39-56. PubMed ID: 770222
[No Abstract] [Full Text] [Related]
7. Immunological study of patients with Hodgkin's disease in long-lasting not-maintained complete remission.
Gobbi M; Fiacchini M; Tomasini I; Ruggero D; Lauria F; Tura S
Boll Ist Sieroter Milan; 1977 Mar; 56(2):144-51. PubMed ID: 326273
[TBL] [Abstract][Full Text] [Related]
8. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
Lang JM; Bigel P; Oberling F; Mayer S
Pathol Biol (Paris); 1978; 26(3-4):159-62. PubMed ID: 355984
[TBL] [Abstract][Full Text] [Related]
9. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
Lang JM; Bigel P; Oberling F; Mayer S
Sem Hop; 1978 Nov 8-15; 54(37-40):1155-8. PubMed ID: 217096
[TBL] [Abstract][Full Text] [Related]
10. Ecotaxis: the principle and its application to the study of Hodgkin's disease.
Sousa MD; Yang M; Lopes-Corrales E; Tan C; Hansen JA; Dupont B; Good RA
Clin Exp Immunol; 1977 Jan; 27(1):143-51. PubMed ID: 300302
[TBL] [Abstract][Full Text] [Related]
11. [Long term effects of splenectomy on the immune-status of Hodgkin's disease patients depending on the modality of treatment (author's transl)].
Schaadt M; Diehl V; Kalden JR; Schmidt N; Laskewitz E
Med Klin; 1978 Oct; 73(40):1381-8. PubMed ID: 309061
[TBL] [Abstract][Full Text] [Related]
12. [The bone marrow in Hodgkin's disease following radiotherapy and splenectomy].
Baĭsogolov GD; Pavlov VV; Bogatyreva TI; Khait SE; Kuz'mina EG
Med Radiol (Mosk); 1987 May; 32(5):3-7. PubMed ID: 3586920
[TBL] [Abstract][Full Text] [Related]
13. A micro-method for PHA-induced stimulation of human lymphocytes. II. communication: effect of splenectomy on the inhibitory activity of serum in patients with Hodgkin's disease.
Pappas A; Pees H; Girmann G
Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):1-10. PubMed ID: 868205
[TBL] [Abstract][Full Text] [Related]
14. Rosette-forming lymphocytes in Hodgkin's disease.
Cohnen G; Augener W; Brittinger G; Douglas SD
N Engl J Med; 1973 Oct; 289(16):863. PubMed ID: 4543492
[No Abstract] [Full Text] [Related]
15. Changes in human lymphocyte subpopulation in Hodgkin's lymphoma.
Rejthar A; Patera J; Rejtharová A; Hrdlicková N
Neoplasma; 1976; 23(4):371-5. PubMed ID: 1087377
[TBL] [Abstract][Full Text] [Related]
16. Circulating lymphoid cells in Hodgkin's disease.
Fairley GH
Natl Cancer Inst Monogr; 1973 May; 36():95-8. PubMed ID: 4270378
[No Abstract] [Full Text] [Related]
17. [Evaluation of the immunological status of patients with Hodgkin's disease].
Rambotti P; Velardi A; Spinozzi F; Aversa F; Falini B
Ann Sclavo; 1978; 20(3):225-38. PubMed ID: 310660
[No Abstract] [Full Text] [Related]
18. [Immunity and hypersensitivity in Hodgkin's lymphoma].
Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
[No Abstract] [Full Text] [Related]
19. Autologous rosette-forming capacity of T-lymphocytes in Hodgkin's disease.
Bodolay E; Berényi E; Sonkoly I; Szegedi G
Acta Med Hung; 1984; 41(2-3):113-9. PubMed ID: 6611543
[TBL] [Abstract][Full Text] [Related]
20. [Effect of splenectomy on hematological tolerance and the results of chemotherapy in Hodgkin's disease].
Robak T; Płuzańska A; Dmochowska M; Krykowski E; Oliskiewicz W; Fajndt S; Maciejczyk J; Jabłkowski W; Mazurowa A
Acta Haematol Pol; 1982; 13(1-2):5-11. PubMed ID: 7180356
[No Abstract] [Full Text] [Related]
[Next] [New Search]
